Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024

GAITHERSBURG, Md., Feb. 20, 2024 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its fourth quarter and full year 2023 financial results and operational highlights at 8:30 a.m. Eastern Standard Time (EST) on Wednesday, February 28, 2024. Details of the event and replay … Read more

Why Montgomery Co. officials are cheering the just-approved Novavax COVID-19 vaccines

Montgomery County Executive Marc Elrich said the Novavax vaccine is a protein-based vaccine, as opposed to the mRNA vaccines already on the market. Novavax, a biotech firm based in Gaithersburg, Maryland, has been granted emergency FDA authorization for its version of a COVID-19 vaccine — and local officials hope it will encourage more people to … Read more

Gaithersburg’s Novavax COVID booster delayed in EU, approved in UK

Regulators in the United Kingdom have approved full marketing authorization for Gaithersburg-based Novavax’s updated, protein-based COVID-19 booster shot, but regulators in the European Union have delayed a decision. Regulators in the United Kingdom have approved full marketing authorization for Gaithersburg-based Novavax’s updated, protein-based COVID-19 booster shot, but regulators in the European Union have delayed a … Read more